Pharmaceuticals giant AstraZeneca is accelerating the shift in its centre of gravity to the US. The move, under chief executive Pascal Soriot, will be a boost for Donald Trump's incoming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback